Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Rixe

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
Phase I and pharmacokinetic study of the camptothecin analog DX-8951f administered as a 30-minute infusion every 3 weeks in patients with advanced cancerV Boige, E Raymond, S Faivre, et al.
American Journal of Clinical Oncology|October 1, 1995
A phase II study of tamoxifen combined with cisplatin-interleukin 2 and alpha-interferon in metastatic melanomaE C Antoine, O Rixe, E Vuillemin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanomaD Khayat, C Borel, J M Tourani, et al.
Cancer|March 20, 1998
Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinomaK Fizazi, I Cojean, J P Pignon, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy?K Fizazi, S Culine, J P Droz, et al.
International Journal of Medical Sciences|June 21, 2008
Breast cancer screening in France: results of the EDIFICE surveyX Pivot, O Rixe, Jf Morere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Dose-finding study of weekly 24-h continuous infusion of 5-fluorouracil associated with alternating oxaliplatin or irinotecan in advanced colorectal cancer patientsL Cals, O Rixe, E François, et al.
Seminars in Oncology|February 1, 1997
Preliminary results of a phase I/II study of paclitaxel, cisplatin, and cyclophosphamide in advanced ovarian carcinomaD Coeffic, A Benhammouda, E C Antoine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II studyI Monnet, Cremoux H de, P Soulié, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastomaE Raymond, M Fabbro, V Boige, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
Phase I and pharmacokinetic study of the camptothecin analog DX-8951f administered as a 30-minute infusion every 3 weeks in patients with advanced cancerV Boige, E Raymond, S Faivre, et al.
American Journal of Clinical Oncology|October 1, 1995
A phase II study of tamoxifen combined with cisplatin-interleukin 2 and alpha-interferon in metastatic melanomaE C Antoine, O Rixe, E Vuillemin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanomaD Khayat, C Borel, J M Tourani, et al.
Cancer|March 20, 1998
Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinomaK Fizazi, I Cojean, J P Pignon, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy?K Fizazi, S Culine, J P Droz, et al.
International Journal of Medical Sciences|June 21, 2008
Breast cancer screening in France: results of the EDIFICE surveyX Pivot, O Rixe, Jf Morere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Dose-finding study of weekly 24-h continuous infusion of 5-fluorouracil associated with alternating oxaliplatin or irinotecan in advanced colorectal cancer patientsL Cals, O Rixe, E François, et al.
Seminars in Oncology|February 1, 1997
Preliminary results of a phase I/II study of paclitaxel, cisplatin, and cyclophosphamide in advanced ovarian carcinomaD Coeffic, A Benhammouda, E C Antoine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II studyI Monnet, Cremoux H de, P Soulié, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastomaE Raymond, M Fabbro, V Boige, et al.
Pageof 7